1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists-Reference-Cited by-同舟云学术

1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists

Published:2009-11-05 Issue:1 Volume:53 Page:374-391
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Micheli Fabrizio¹²,Arista Luca³,Bonanomi Giorgio¹²,Blaney Frank E.⁴⁵,Braggio Simone¹²,Capelli Anna Maria⁴²,Checchia Anna¹²,Damiani Federica⁶,Di-Fabio Romano¹²,Fontana Stefano¹²,Gentile Gabriella¹²,Griffante Cristiana¹²,Hamprecht Dieter⁷,Marchioro Carla⁴²,Mugnaini Manolo¹²,Piner Jacqui⁸⁵,Ratti Emiliangelo¹⁵,Tedesco Giovanna⁴²,Tarsi Luca¹²,Terreni Silvia¹²,Worby Angela⁴⁵,Ashby Charles R.⁹,Heidbreder Christian¹⁰

Affiliation:

1. Neurosciences Centre of Excellence

2. GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy

3. Novartis Institute Research, Basel, Switzerland

4. Molecular Discovery Research

5. GlaxoSmithKline Medicines Research Centre, NFSP, Harlow, U.K.

6. European Patent Office, Munich, Germany

7. Boehringer Ingelheim, Milan, Italy

8. Safety Assessment

9. Department of Pharmaceutical Sciences, Saint John’s University, Jamaica, New York 11439

10. Reckitt Benckiser Pharmaceuticals, Richmond, Virginia 23235

Publisher